Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis

Código QR

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis

Noll Campbell1, Amir Ayub2, Malaz A Boustani2, Chris Fox3, Martin Farlow4, Ian Maidment3, Robert Howard51Wishard Health Services, Indianapolis, Indiana; 2Indiana University Center for Aging Research, Regenstrief Institute, Inc., Indianapolis, Indiana; 3University of Kent, Kent, United Kingdom; 4Indi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Noll Campbell, Amir Ayub, Malaz A Boustani, Chris Fox, Martin Farlow, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Alzheimer's disease dementia cholinesterase inhibitors behavioral and psychological symptoms Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/5cd558d253c44852b6471ca244f81b4c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

A longitudinal study of risk factors for community-based home help services in Alzheimer’s disease: the influence of cholinesterase inhibitor therapy
por: Wattmo C, et al.
Publicado: (2013)

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment
por: Pai MC, et al.
Publicado: (2015)

Antagonism of morphine-induced central respiratory depression by donepezil in the anesthetized rabbit
por: TSUJITA,MIKI, et al.
Publicado: (2007)

Discovery of Guanidine Derivatives from <i>Buthus martensii</i> Karsch with Metal-Binding and Cholinesterase Inhibition Properties
por: Yu-Ming Liu, et al.
Publicado: (2021)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
por: Yoshiyuki Kagawa, et al.
Publicado: (2021)

Patient characteristics associated with screening positive for Alzheimer’s disease and related dementia
por: Fowler NR, et al.
Publicado: (2018)

New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia
por: Kung FC, et al.
Publicado: (2012)

Editorial: Alzheimer's Disease From a Psychiatric Perspective: Towards New Therapeutic Guidelines?
por: Marc Fakhoury, et al.
Publicado: (2021)

Donepezil reverses buprenorphine-induced central respiratory depression in anesthetized rabbits
por: SAKURABA,SHIGEKI, et al.
Publicado: (2009)

Relation of Breast Cancer and Malathion Aerial Spraying in Arica, Chile
por: Cabello,Gertrudis, et al.
Publicado: (2013)

Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting
por: Nakagawa R, et al.
Publicado: (2017)

Late onset Alzheimer’s disease in older people
por: Ahmet Turan Isik
Publicado: (2010)

Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction
por: Han Y, et al.
Publicado: (2019)

Enfermedad de Alzheimer: Actualización en terapia farmacológica
por: Fuentes G,Patricio, et al.
Publicado: (2005)

Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
por: Subramanian Madhusoodanan, et al.
Publicado: (2008)

Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions
por: Millán-Calenti JC, et al.
Publicado: (2016)

Red neural por defecto y enfermedad de Alzheimer
por: Vergara E,Fernando, et al.
Publicado: (2013)

Phenolic composition, antioxidant activity, anticholinesterase potential and modulatory effects of aqueous extracts of some seaweeds on β-amyloid aggregation and disaggregation
por: Tosin A. Olasehinde, et al.
Publicado: (2019)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009)

Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
por: Adams CD
Publicado: (2020)

Comunicación diagnóstica en enfermedad de Alzheimer: Reflexión y propuesta
por: Fuentes R,Paola, et al.
Publicado: (2012)

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease
por: Chang YP, et al.
Publicado: (2019)

Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
por: Mannu P, et al.
Publicado: (2011)

The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer’s Disease Population
por: Shi Q, et al.
Publicado: (2020)

Practical clinical tool to monitor dementia symptoms: the HABC-Monitor
por: Monahan PO, et al.
Publicado: (2012)

Effectiveness and Safety of Aromatherapy in Managing Behavioral and Psychological Symptoms of Dementia: A Mixed-Methods Systematic Review
por: Becky Siu Yin Li, et al.
Publicado: (2021)

Alzheimer's care today

PSEN1 L226F mutation in a patient with early-onset Alzheimer’s disease in Korea
por: Bagyinszky E, et al.
Publicado: (2016)

Abnormal functional connectivity of the posterior cingulate cortex is associated with depressive symptoms in patients with Alzheimer’s disease
por: Zhang J, et al.
Publicado: (2017)

Different durations of cognitive stimulation therapy for Alzheimer’s disease: a systematic review and meta-analysis
por: Chen J, et al.
Publicado: (2019)

UPLC-MS/MS Profiling, Antioxidant, α-Glucosidase Inhibitory, Cholinesterase Inhibitory, and Cardiovascular Protection Potentials of Jialing 20 (<i>Morus multicaulis</i> Perr.) Mulberry Branch Extract
por: Wei Xiang, et al.
Publicado: (2021)

Síntomas psicológicos y conductuales asociados a demencias: actualización terapéutica
por: Slachevsky Ch,Andrea, et al.
Publicado: (2005)

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy
por: Campbell NL, et al.
Publicado: (2015)

Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020)

Validación de un test de tamizaje para el diagnóstico de demencia asociada a edad, en Chile
por: Quiroga L,Pilar, et al.
Publicado: (2004)

Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
por: Lin CH, et al.
Publicado: (2020)

Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
por: Longfei Jia, et al.
Publicado: (2021)

Public–private partnerships improve health outcomes in individuals with early stage Alzheimer’s disease
por: Galvin JE, et al.
Publicado: (2014)

Evaluation of a computer-assisted errorless learning-based memory training program for patients with early Alzheimer’s disease in Hong Kong: a pilot study
por: Lee GY, et al.
Publicado: (2013)